Robert Bird

Purdue Pharma bypasses state drug monitoring

Posted on May 24, 2019 by Scott Slater III

Norwalk Hour – Connecticut’s newly unredacted lawsuit against Purdue Pharma excoriates the owners and former executives of the OxyContin maker for allegedly fueling the opioid crisis. It does not lambast public officials.

Lawsuit: Sackler Emails ‘Shocking and Offensive’ to Opioid Victims

Posted on May 8, 2019May 13, 2019 by Melissa Ferrigno

CT Post – Connecticut Attorney General William Tong released Tuesday an unredacted version of the state’s lawsuit against OxyContin maker Purdue Pharma, revealing emails from 2001 that he said showed company co-owner and former CEO and President Richard Sackler’s “shocking and offensive” disregard for victims of the opioid crisis — an assertion contested by Sackler’s attorney.

Connecticut Turns Up Pressure on OxyContin Maker Purdue Pharma

Posted on April 23, 2019May 7, 2019 by Melissa Ferrigno

CT Post – Connecticut’s expanded lawsuit against Purdue Pharma and its owners positions the state to more aggressively pursue its claims, but does not assure a full redress of its allegations of deceptive marketing and fraudulent finances against the much-maligned OxyContin maker.

British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.

Posted on April 11, 2019 by Scott Slater III

NPR – Share prices for the British drugmaker Indivior plunged today on the London Stock Exchange. The drop came on news that the U.S. Justice Department indicted the company on fraud and conspiracy charges.

Many sue OxyContin maker, but not its own city: Stamford

Posted on March 4, 2019April 2, 2019 by Scott Slater III

Westport News – Six of the state’s 10 largest cities, and hundreds of others across the country, have sued OxyContin maker Purdue Pharma. So has Connecticut’s attorney general and more than 30 of his counterparts.

Opioids: Boston trial opens what could be year of reckoning for executives

Posted on February 27, 2019March 1, 2019 by

The Guardian – Drug company executives appearing in court in Boston this week have been accused of running “a criminal enterprise” and putting greed before patient safety as they pushed prescription narcotics during the opioids crisis, blighting the health of America.

Purdue Pharma to research non-opioid treatments

Posted on January 9, 2019December 18, 2020 by Scott Slater III

Daily Heralds – Purdue Pharma, the controversial maker of OxyContin, and eyecare-pharmaceutical firm Ocular Therapeutix has announced a research partnership aiming to develop non-opioid pain treatments.

Read article

Point72 gender-discrimination lawsuit moves to arbitration

Posted on October 9, 2018October 10, 2018 by Scott Slater III

Stamford Advocate– The executive suing Point72 Asset Management for alleged gender discrimination and the Stamford-based firm have agreed to have her case dismissed in court and decided by a private arbitrator, according to documents filed in the past week.

Purdue Pharma grapples with growing protests

Posted on August 27, 2018August 27, 2018 by

Stamford Advocate– Controversy surrounding Purdue Pharma’s role in the opioid crisis has spilled from the courtrooms into the streets.

Congressional Committee Investigates Purdue Pharma

Posted on August 7, 2018 by Melissa Ferrigno

Stamford Advocate– Purdue Pharma is facing questions from a Congressional committee investigating the opioid crisis, opening another round of scrutiny for the embattled maker of OxyContin.

School of Business

About the School

Campuses

News & Events

Contact

Undergraduate Degree

Graduate Programs

MBA Programs

Specialized Masters

Professional Development

Overview

Academic Areas

Faculty & Ph.D.s

Research Centers

Recruit

Centers, Institutes, & Initiatives

Experiential Learning